Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Mbio|July 20, 2021
Engineered Type Six Secretion Systems Deliver Active Exogenous Effectors and Cre RecombinaseSteven J Hersch, Linh Lam, Tao G DongCanadian Journal of Gastroenterology & Hepatology|July 26, 2017
Comparative Readability Analysis of Online Patient Education Resources on Inflammatory Bowel DiseasesRishabh Gulati, Mohammad Nawaz, Linh Lam, et al.ACS Applied Materials & Interfaces|November 10, 2023
Biodegradable and pH-Responsive Amphiphilic Poly(succinimide) Derivatives for Triggered Release of Antibiotics for Management of Infected WoundsDieu-Linh Lam, Ying-Tzu Cheng, Chun-Jen HuangFrontiers in Cell and Developmental Biology|July 29, 2024
Innate neuroimmunity across aging and neurodegeneration: a perspective from amyloidogenic evolvabilityGilbert Ho, Linh Lam, Tony Tran, et al.Proceedings of the National Academy of Sciences of the United States of America|July 8, 2015
Identification of divergent type VI secretion effectors using a conserved chaperone domainXiaoye Liang, Richard Moore, Mike Wilton, et al.Nature Microbiology|April 11, 2018
A type VI secretion system effector delivery mechanism dependent on PAAR and a chaperone-co-chaperone complexBrianne J Burkinshaw, Xiaoye Liang, Megan Wong, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2005
Noninvasive imaging of ex vivo intracoronarily delivered nonviral therapeutic transgene expression in heartLuyi Sen, Sanjiv S Gambhir, Hiroshi Furukawa, et al.Applied and Environmental Microbiology|December 8, 2019
A Comprehensive Account of Escherichia coli Sequence Type 131 in Wastewater Reveals an Abundance of Fluoroquinolone-Resistant Clade A StrainsThomas J Finn, Lena Scriver, Linh Lam, et al.Nature Microbiology|February 26, 2020
Envelope stress responses defend against type six secretion system attacks independently of immunity proteinsSteven J Hersch, Nobuhiko Watanabe, Maria Silvina Stietz, et al.Pharmacotherapy|April 28, 2007
Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapyDeborah DeEugenio, Louis Kolman, Matthew DeCaro, et al.Pageof 2